Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells

Brain Research Bulletin

Volumn 62, Issue 3, 2003, Pages 223-229

  Datki, Zsolt ^a   Juhász, Anna ^a   Gálfi, Márta ^a   Soós, Katalin ^a   Papp, Rita ^a   Zádori, Dénes ^a   Penke, Botond ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

MTT assay; Neuroblastoma cells; Neurotoxicity; SH SY5Y; Amyloid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; BROMINE DERIVATIVE; PRION PROTEIN;

ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEURITE; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 0346492847     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2003.09.011     Document Type: Article

References (30)

1. Abe K., Saito H. Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci. Res. 31(4):1998;295-305.
2. Ba F., Pang P.K., Benishin C.G. The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J. Neurosci. Methods. 123(1):2003;11-22.
3. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23(7):2003;2665-2674.
4. Cedazo-Minguez A., Huttinger M., Cowburn R.F. Beta-VLDL protects against A beta(1-42) and apoE toxicity in human SH-SY5Y neuroblastoma cells. Neuroreport. 12(2):2001;201-206.
5. Chabry J., Ratsimanohatra C., Sponne I., Elena P.P., Vincent J.P., Pillot T. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression. J. Neurosci. 23(2):2003;462-469.
6. Combs C.K., Bates P., Karlo J.C., Landreth G.E. Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem. Int. 39(5/6):2001;449-457.
7. -3. M delta-aminolevulinic acid in primary neural tissue cultures Neurochem. Res. 12(5):1987;465-468.
8. Ghiso J., Frangione B. Amyloidosis and Alzheimer's disease. Adv. Drug Deliv. Rev. 54(12):2002;1539-1551. (review).
9. Huemer R.P., Lee K.D. Automated Lowry method for microgram protein determination. Anal. Biochem. 37(1):1970;149-153.
10. Janka Z., Szentistvanyi I., Juhasz A., Rimanoczy A. Difference in lithium transport between neurones and glia in primary culture. Neuropharmacology. 19(9):1980;827-830.
11. Kumar A., Hovland A.R., La Rosa F.G., Cole W.C., Prasad J.E., Prasad K.N. Relative sensitivity of undifferentiated and cyclic adenosine 3′,5′-monophosphate-induced differentiated neuroblastoma cells to cyclosporin A: potential role of beta-amyloid and ubiquitin in neurotoxicity. In Vitr. Cell. Dev. Biol. Anim. 36(2):2000;81-87.
12. Lambert M.P., Stevens G., Sabo S., Barber K., Wang G., Wade W., Krafft G., Snyder S., Holzman T.F., Klein W.L. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 39(4):1994;377-385.
13. Li Y.P., Bushnell A.F., Lee C.M., Perlmutter L.S., Wong S.K. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738(2):1996;196-204.
14. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69(2):1997;581-593.
15. Liu Y., Schubert D. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J. Neurochem. 69(6):1997;2285-2293.
16. Loske C., Neumann A., Cunningham A.M., Nichol K., Schinzel R., Riederer P., Munch G. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J. Neural. Trans. 105(8/9):1998;1005-1015.
17. Malouf A.T. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol. Aging. 13(5):1991;543-551.
18. Nordin-Andersson M., Forsby A., Heldring N., DeJongh J., Kjellstrand P., Walum E. Neurite degeneration in differentiated human neuroblastoma cells. Toxicol. In Vitr. 12:1998;557-560.
19. O'Donovan C.N., Tobin D., Cotter T.G. Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J. Biol. Chem. 276(47):2001;43516-43523.
20. Palotas A., Kalman J., Palotas M., Juhasz A., Janka Z., Penke B. Beta-amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones. Brain Res. Bull. 58(2):2002;203-205.
21. Rumora L., Hadzija M., Barisic K., Maysinger D., Grubiic T.Z. Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases. Biol. Chem. 383(11):2002;1751-1758.
22. Schiff D., Chan G., Poznansky M.J. Bilirubin toxicity in neural cell lines N115 and NBR10A. Pediatr. Res. 19(9):1985;908-911.
23. M. Sensenbrenner, Dissociated brain cells in primary cultures, in: Cell Tissue and Organ Cultures in Neurobiology, Academic Press, New York, 1984, pp. 191-212.
24. Smith M.A., Drew K.L., Nunomura A., Takeda A., Hirai K., Zhu X., Atwood C.S., Raina A.K., Rottkamp C.A., Sayre L.M., Friedland R.P., Perry G. Amyloid-beta tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs. Neurochem. Int. 40(6):2002;527-531.
25. Soriano F.X., Galbete J.L., Forloni G. Effect of beta-amyloid on endothelial cells: lack of direct toxicity, enhancement of MTT-induced cell death and intracellular accumulation. Neurochem. Int. 43(3):2003;251-261.
26. Takenouchi T., Munekata E. Amyloid beta-peptide-induced inhibition of MTT reduction in PC12h and C1300 neuroblastoma cells: effect of nitroprusside. Peptides. 19(2):1998;365-372.
27. Volm M., Wayss K., Kaufmann M., Mattern J. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur. J. Cancer. 15(7):1979;983-993.
28. Webster N.J., Green K.N., Peers C., Vaughan P.F. Altered processing of amyloid precursor protein in the human neuroblastoma SH-SY5Y by chronic hypoxia. J. Neurochem. 83(6):2002;1262-1271.
29. Wei H., Leeds P.R., Qian Y., Wei W., Chen R., Chuang D. Beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment. Eur. J. Pharmacol. 392(3):2000;117-123.
30. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250(4978):1990;279-282.